Adial Pharmaceuticals (ADIL) Return on Assets (2022 - 2024)
Adial Pharmaceuticals' Return on Assets history spans 3 years, with the latest figure at 1.91% for Q3 2024.
- For Q3 2024, Return on Assets fell 171.0% year-over-year to 1.91%; the TTM value through Sep 2024 reached 1.91%, down 171.0%, while the annual FY2023 figure was 0.36%, N/A changed from the prior year.
- Return on Assets for Q3 2024 was 1.91% at Adial Pharmaceuticals, down from 1.55% in the prior quarter.
- Across five years, Return on Assets topped out at 0.49% in Q4 2023 and bottomed at 1.91% in Q3 2024.
- The 3-year median for Return on Assets is 1.17% (2023), against an average of 0.95%.
- The largest annual shift saw Return on Assets skyrocketed 186bps in 2023 before it crashed -171bps in 2024.
- A 3-year view of Return on Assets shows it stood at 1.36% in 2022, then skyrocketed by 136bps to 0.49% in 2023, then tumbled by -487bps to 1.91% in 2024.
- Per Business Quant, the three most recent readings for ADIL's Return on Assets are 1.91% (Q3 2024), 1.55% (Q2 2024), and 0.69% (Q1 2024).